plko 3 thy1 1 cd90 1 vector (Addgene inc)
Addgene inc is a verified supplier 
91
Structured Review
Addgene inc
plko 3 thy1 1 cd90 1 vector
Plko 3 Thy1 1 Cd90 1 Vector, supplied by Addgene inc, used in various techniques. Bioz Stars score: 91/100, based on 4 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/plko+3+thy1+1+cd90+1+vector/pPD95_03+(Plasmid+%231479)/pm41826695-319-18-22
Average 91 stars, based on 4 article reviews
Plko 3 Thy1 1 Cd90 1 Vector, supplied by Addgene inc, used in various techniques. Bioz Stars score: 91/100, based on 4 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/plko+3+thy1+1+cd90+1+vector/pPD95_03+(Plasmid+%231479)/pm41826695-319-18-22
Average 91 stars, based on 4 article reviews
plko 3 thy1 1 cd90 1 vector - by Bioz Stars,
2026-09
91/100 stars
Images
Related Articles
FACS:Article Title: Palmitoylation-mediated regulation of KAT2A promotes lung metastasis in breast cancer. Article Snippet: Acetylation is frequently dysregulated in cancer, and b ot h a ce ty lt ra ns ferase and deacetylase inhibitors are being evaluated at various stages of preclinical and clinical development.. However, how the expression of a c e ty l t ra n s ferases and deacetylases is regulated remains often elusive.. We focused on the lysine a c e ty l t ra n s ferase 2A (KAT2A) as it is important in multiple cancer indications with a clinical inhibitor in development. Isolation:Article Title: Palmitoylation-mediated regulation of KAT2A promotes lung metastasis in breast cancer. Article Snippet: Acetylation is frequently dysregulated in cancer, and b ot h a ce ty lt ra ns ferase and deacetylase inhibitors are being evaluated at various stages of preclinical and clinical development.. However, how the expression of a c e ty l t ra n s ferases and deacetylases is regulated remains often elusive.. We focused on the lysine a c e ty l t ra n s ferase 2A (KAT2A) as it is important in multiple cancer indications with a clinical inhibitor in development. In Vivo:Article Title: Palmitoylation-mediated regulation of KAT2A promotes lung metastasis in breast cancer. Article Snippet: Acetylation is frequently dysregulated in cancer, and b ot h a ce ty lt ra ns ferase and deacetylase inhibitors are being evaluated at various stages of preclinical and clinical development.. However, how the expression of a c e ty l t ra n s ferases and deacetylases is regulated remains often elusive.. We focused on the lysine a c e ty l t ra n s ferase 2A (KAT2A) as it is important in multiple cancer indications with a clinical inhibitor in development. Transduction:Article Title: Palmitoylation-mediated regulation of KAT2A promotes lung metastasis in breast cancer. Article Snippet: Acetylation is frequently dysregulated in cancer, and b ot h a ce ty lt ra ns ferase and deacetylase inhibitors are being evaluated at various stages of preclinical and clinical development.. However, how the expression of a c e ty l t ra n s ferases and deacetylases is regulated remains often elusive.. We focused on the lysine a c e ty l t ra n s ferase 2A (KAT2A) as it is important in multiple cancer indications with a clinical inhibitor in development. Plasmid Preparation:Article Title: Palmitoylation-mediated regulation of KAT2A promotes lung metastasis in breast cancer. Article Snippet: Acetylation is frequently dysregulated in cancer, and b ot h a ce ty lt ra ns ferase and deacetylase inhibitors are being evaluated at various stages of preclinical and clinical development.. However, how the expression of a c e ty l t ra n s ferases and deacetylases is regulated remains often elusive.. We focused on the lysine a c e ty l t ra n s ferase 2A (KAT2A) as it is important in multiple cancer indications with a clinical inhibitor in development. |